Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection

NARecruitingINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2026

Conditions
Stem Cell TransplantAllogeneic
Interventions
DEVICE

CliniMACS CD34 Reagent system

A special machine that separates out the donor cells that have been mixed with a special protein, CD34 antibody, that binds to the stem cells from the white blood cells.

Trial Locations (2)

77030

RECRUITING

Houston Methodist Hospital, Houston

RECRUITING

Texas Children's Hospital, Houston

All Listed Sponsors
collaborator

Center for Cell and Gene Therapy, Baylor College of Medicine

OTHER

collaborator

The Methodist Hospital Research Institute

OTHER

lead

Baylor College of Medicine

OTHER

NCT01189786 - Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection | Biotech Hunter | Biotech Hunter